Aug 31, 2018
Amneal to Present at Upcoming Investor Conferences
Aug 31, 2018
Amneal Announces Partnership with American Regent on Generic Makena® and Progress on its Business Plan with Additional ANDA Approvals and Launches
Aug 20, 2018
Amneal Announces 10-Year Licensing and Supply Agreement with Jerome Stevens Pharmaceuticals, Inc. for Levothyroxine
Aug 09, 2018
Amneal Announces Solid Second Quarter 2018 Financial Results
Jul 23, 2018
Amneal Announces FDA Approval and Launch of Generic Potassium Chloride Oral Solution
Jun 29, 2018
Amneal to Report Second Quarter 2018 Results on August 9, 2018
Jun 29, 2018
Amneal Announces Favorable Ruling Regarding Patent Validity for Zomig® (zolmitriptan) Nasal Spray
Jun 20, 2018
Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary®
Jun 06, 2018
Amneal to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
May 30, 2018
Amneal Announces FDA Approval of Cyclophosphamide for Injection USP, Generic to Cytoxan®
May 18, 2018
Amneal Pharmaceuticals Celebrates Combination by Ringing Opening Bell at New York Stock Exchange
May 17, 2018
Amneal Announces FDA Approval and Launch of Generic Welchol® (Colesevelam HCl) Tablets, 625 mg
May 15, 2018
Amneal Introduces First Generic for Mephyton® (Phytonadione) Tablets, 5mg
May 14, 2018
Amneal to Present at the UBS Global Healthcare Conference
May 11, 2018
Amneal Announces Actions to Streamline Operations and Capture Cost Synergies
May 07, 2018
Amneal Initiates Phase 3 Study for IPX203, an Investigational Extended-Release Formulation of Carbidopa-Levodopa (CD-LD) in Advanced Parkinson's Disease Patients
May 07, 2018
Amneal and Impax Complete Business Combination